Department of Surgery, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Thyroid. 2012 Jan;22(1):44-52. doi: 10.1089/thy.2011.0260. Epub 2011 Dec 5.
A combination of bilateral superficial cervical plexus block (BSCPB) and general anesthesia is recommended for thyroid surgery. Proof of the efficacy of this combination remains weak. Furthermore, data on the safety of this regimen are lacking. Therefore, a meta-analysis of randomized controlled trials (RCT) to evaluate the efficacy and safety of BSCPB as an adjunct to general anesthesia in patients receiving thyroid surgery was performed.
A meta-analysis of RCT was performed that included interventional groups evaluating the efficacy of BSCPB 6 and 24 hours after thyroid surgery.
Eight RCT, including a total of 799 patients (463 who underwent BSCPB and 336 controls), were analyzed. A meta-analysis demonstrated a reduction in pain scores 6 hours (Hedges' g: -0.46 [95% CI: -0.74 to -0.19]; p=0.001) and 24 hours postoperatively (Hedges' g: -0.49 [95% CI: -0.71 to -0.27]; p<0.001) in patients who had undergone BSCPB. The relative risk for postoperative nausea and vomiting (PONV) was 0.80 (95% CI: 0.58 to 1.09, p=0.159) in patients receiving BSCPB. Procedure-related adverse events were reported in three of the 476 patients who had undergone BSCPB (0.6%; 95% CI: 0.1% to 2.0%). These three patients had transient paresis of the brachial plexus, combined with a diaphragmatic paresis in one case, and all spontaneously resolved.
The combination of BSCPB and general anesthesia has a significant benefit in reducing pain 6 and 24 hours after thyroid surgery. However, the effect on pain reduction is too small to be of clinical relevance. Although it is a safe procedure, the existing evidence allows for no recommendation concerning the application of BSCPB in thyroid surgery. Further trials should evaluate a dose-response relationship and the incidence of PONV with this regimen.
甲状腺手术推荐采用双侧颈浅丛阻滞(BSCPB)联合全身麻醉。这种联合方案的疗效证据仍然不足。此外,关于该方案安全性的数据也缺乏。因此,进行了一项荟萃分析,评估 BSCPB 联合全身麻醉在甲状腺手术中的有效性和安全性。
对评估甲状腺手术后 6 小时和 24 小时 BSCPB 疗效的干预性 RCT 进行荟萃分析。
共纳入 8 项 RCT,总计 799 例患者(463 例接受 BSCPB,336 例为对照组)。荟萃分析显示,BSCPB 组患者术后 6 小时(Hedges' g:-0.46 [95% CI:-0.74 至-0.19];p=0.001)和 24 小时(Hedges' g:-0.49 [95% CI:-0.71 至-0.27];p<0.001)疼痛评分降低。接受 BSCPB 的患者术后恶心和呕吐(PONV)的相对风险为 0.80(95% CI:0.58 至 1.09,p=0.159)。在接受 BSCPB 的 476 例患者中,报告了 3 例与操作相关的不良事件(0.6%;95% CI:0.1%至 2.0%)。这 3 例患者出现臂丛神经短暂性瘫痪,其中 1 例伴有膈肌瘫痪,所有患者均自行缓解。
BSCPB 联合全身麻醉可显著降低甲状腺手术后 6 小时和 24 小时的疼痛。然而,疼痛缓解的效果太小,没有临床意义。虽然这是一种安全的操作,但现有证据不支持在甲状腺手术中应用 BSCPB。进一步的试验应评估该方案的剂量反应关系和 PONV 的发生率。